🔎 Trials Near Me

Home › Psychotic Disorders › Texas › Dallas

Psychotic Disorders clinical trials in Dallas, TX

6 studies for Psychotic Disorders are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

RecruitingPhase 3
  • Local Institution - 1260, Dallas
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787

Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)

RecruitingHealthy volunteers welcome
  • Parkland Health & Hospital System, Dallas
All ages · All sexes · Updated Jul 9, 2026 · NCT03906435

CLOZAPINE Response in Biotype-1

RecruitingPhase 4
  • UT Southwestern Medical Center, Dallas
Ages 18 to 60 · All sexes · Updated May 11, 2026 · NCT04580134

Database Registry for Neural Network Biomarkers in Psychosis

RecruitingObservational studyHealthy volunteers welcome
  • University of Texas Southwestern Medical Center, Dallas
Ages 18 to 60 · All sexes · Updated Apr 23, 2026 · NCT01409109

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

RecruitingObservational study
  • University of Texas Southwestern Medical Center, Dallas
Ages 18 to 40 · All sexes · Updated Mar 10, 2026 · NCT06740383

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

Recruiting
  • University of Texas at Dallas, Dallas
Ages 18 to 65 · All sexes · Updated Jan 23, 2026 · NCT07098169

About Psychotic Disorders

Psychotic disorders are severe mental disorders that cause abnormal thinking and perceptions. Two main symptoms are delusions and hallucinations. Learn more.

More about Psychotic Disorders on MedlinePlus

Psychotic Disorders trials in other cities

Other studies in Dallas

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.